Related references
Note: Only part of the references are listed.IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol
Petra Dorge et al.
HAEMATOLOGICA (2013)
Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group
Jinghui Zhang et al.
BLOOD (2011)
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
Ching-Hon Pui et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
Richard C. Harvey et al.
BLOOD (2010)
The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function
C. Kox et al.
LEUKEMIA (2010)
Treatment of Childhood Acute Lymphoblastic Leukemia
Martin Stanulla et al.
SEMINARS IN HEMATOLOGY (2009)
Global Genomic Characterization of Acute Lymphoblastic Leukemia
Charles G. Mullighan et al.
SEMINARS IN HEMATOLOGY (2009)
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia
T. Flohr et al.
LEUKEMIA (2008)
The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells
Stephen J. Loughran et al.
NATURE IMMUNOLOGY (2008)
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
EJ Yeoh et al.
CANCER CELL (2002)
Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995
M Schrappe et al.
LEUKEMIA (2000)